Estrella Immunopharma, Inc.
ESLAW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001844417
No open-market purchases or sales by Estrella Immunopharma, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $249.2K in total; no superinvestor holds it.
Other share classesESLA
13F holders, Q2 2024
Institutional positions in Estrella Immunopharma, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +1 vs. Q1 2024
- Shares held
- 626.0K
- −21.3K (−3.3%) vs. Q1 2024
- Total value
- $44.9K
- −$11.4K (−20.3%) vs. Q1 2024
- New holders
- 2
- 1 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ESLAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $249.2K |
| Q1 2026 | 8 | $235.9K |
| Q4 2025 | 9 | $354.1K |
| Q3 2025 | 12 | $26.9K |
| Q2 2025 | 12 | $26.2K |
| Q1 2025 | 11 | $86.1K |
| Q4 2024 | 12 | $78.3K |
| Q3 2024 | 14 | $75.4K |
| Q2 2024 | 15 | $44.9K |
| Q1 2024 | 14 | $56.3K |
| Q4 2023 | 14 | $27.9K |
| Q3 2023 | 1 | $1.75K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Estrella Immunopharma, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Highbridge Capital Management LLC | – | $14.9K | 0.00% | – | – |
| D. E. Shaw & Co., Inc. | 87,500 | $6.93K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 66,112 | $4.56K | 0.00% | 00.0% | Unchanged |
| SkyView Investment Advisors, LLC | 62,500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 45,476 | $3.14K | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 46,485 | $2.70K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 37,188 | $2.57K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 28,691 | $1.98K | 0.00% | +100+0.3% | Added |
| Cowen and Company, LLC | 25,799 | $1.78K | 0.00% | −2,798−9.8% | Reduced |
| Landscape Capital Management, L.L.C. | 13,682 | $944 | 0.00% | 00.0% | Unchanged |
| Robinson Capital Management, LLC | 11,805 | $815 | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 5,703 | $393 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,090 | $183 | 0.00% | +5,090 | New |
| Bank of America Corp | 80 | $3 | 0.00% | +80 | New |
| Boothbay Fund Management, LLC | 189,899 | – | – | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −23,753−100.0% | Sold out |